ArticleJournal of personalized medicine2025

Efficacy of Intravitreal Brolucizumab for Chronic Central Serous Chorioretinopathy: A Pilot Study.

Sunjin Hwang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.